About Atraverse Medical
Atraverse Medical is a Healthcare company based in Chicago (United States) founded in 2022 by Eric Sauter, and was acquired by Johnson & Johnson in April 2026. Next-generation tools for left-heart access are developed for cardiac treatments. Atraverse Medical has raised $61.9 million across 4 funding rounds from investors including Johnson & Johnson. Atraverse Medical offers products and services including Hotwire. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Surgical Devices. Its legal entity is Atraverse Medical, Inc. Its competitors include Helios Cardio, Terumo Neuro and ONOCOR.
Company details
Atraverse Medical was founded in 2022 and is based in Chicago, United States. Medical devices and procedures are developed by the company to enable surgeons to access the left side of the heart. These tools address heart failure and related conditions within the cardiovascular sector. Operations focus on innovation in interventional cardiology, with an emphasis on procedural efficiency and patient outcomes.
- Headquarters Chicago, United States
- Founders Eric Sauter
- Stage Acquired
- SectorsHealthcare
- Website atraversemedical.com
- Social LinkedIn
- Acquired by Johnson & Johnson (Apr 2026)
- Legal Name Atraverse Medical, Inc.
- Total Equity Funding$61.9M (USD)
in 4 rounds
- Latest Funding Round$29.4M (USD), Series A
Apr 2025
- Investors
- Acquired byJohnson & Johnson
(Apr 2026)
Products & Services of Atraverse Medical
Atraverse Medical offers a comprehensive portfolio of products and services, including Hotwire.
Guidewire for RF-enabled transeptal puncture in cardiac procedures.
Funding Insights of Atraverse Medical
Atraverse Medical has successfully raised a total of $61.9M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $29.4 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $61.9M
- Total Rounds 4
- Last Round Series A — $29.4M
- First Round $5M
(Feb 2023)
All 4 funding rounds of Atraverse Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2025 | $29.4M | Series A | – | – | – |
| Feb 2025 | $15M | Series A | – | – | – |
| May 2024 | $12.5M | Seed | – | – | – |
| Feb 2023 | $5M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Atraverse Medical
Atraverse Medical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Johnson & Johnson.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | jnj.com | New Brunswick, United States |
Investor details for Atraverse Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Atraverse Medical
6 people are tracked at Atraverse Medical (5 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Eric Sauter | Co-Founder | Leadership |
Tyler Strang | VP Of Engineering | Leadership |
Jay K. | Chief Marketing Officer | Leadership |
Brandon Allen | Vice President Of Sales | Leadership |
John Slump | Ceo/president & Co-founder | Leadership |
Delaney Kepple | Training And Development Consultant | Team |
Complete people profiles for Atraverse Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Atraverse Medical
4 dated milestones of Atraverse Medical across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Atraverse Medical is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series A, of $29.4M.
- Exit Acquired by Johnson & Johnson.
Competitors of Atraverse Medical
Atraverse Medical has 3 listed competitors in our database. They include Helios Cardio, Terumo Neuro and ONOCOR.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helioscardio.com | 2019 | Weston, United States | Develops biologic matrices for cardiac repair and regeneration of heart conditions. | |||
| terumoneuro.com | 1997 | Aliso Viejo, United States | Provides medical devices for hemorrhagic and ischemic stroke care worldwide. | |||
| onocorvascular.com | 2022 | Philadelphia, United States | ŌNŌ creates medical devices for percutaneous heart implant retrieval and structural interventions. |
Detailed competitors of Atraverse Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Atraverse Medical
Websites that share an audience with Atraverse Medical (atraversemedical.com).
Websites whose visitors overlap most with Atraverse Medical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cardiovascularnews.com | cardiovascularnews.com | 100% | #3,420,366 | – |
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Atraverse Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Atraverse Medical
Complete news archive for Atraverse Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atraverse Medical
Atraverse Medical was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Atraverse Medical is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Atraverse Medical is a funded company, having raised a total of $61.9M across 4 funding rounds to date. The company's 1st funding round was a Seed of $5M, raised on Feb 2023.
Atraverse Medical was founded in 2022 and is based in Chicago, United States. Medical devices and procedures are developed by the company to enable surgeons to access the left side of the heart. These tools address heart failure and related conditions within the cardiovascular sector. Operations focus on innovation in interventional cardiology, with an emphasis on procedural efficiency and patient outcomes.
Atraverse Medical's top competitors include Helios Cardio, Terumo Neuro and ONOCOR.
Atraverse Medical offers Hotwire.
Atraverse Medical has 1 investor. Key investors include Johnson & Johnson.
Atraverse Medical operates through Atraverse Medical, Inc..
Yes. Atraverse Medical was acquired by Johnson & Johnson in April 2026.